FDA Device Intelligence
Home › ANACAPA TECHNOLOGIES, INC. › Silver-sept Silver Antimicrobial Skin and Wound Gel

Silver-sept Silver Antimicrobial Skin and Wound Gel

ANACAPA TECHNOLOGIES, INC. · Model 3015S · UDI-DI 00367180300154

FRO Prescription
1
510(k) clearances
3,166
Adverse events (64 deaths)
82
Recalls
385
Facilities

Description

Silver-sept® Antimicrobial Skin and Wound Gel, containing 200ug/gram total silver, is a clear amorphous hydrogel wound dressing. Silver-sept will not stain or discolor tissue. Silver-sept® gel functions as a long-lasting antimicrobial barrier by inhibiting the growth of common bacteria such as: Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Serratia marcescens including the antibiotic resistant strains Methicillin resistant Staphylococcus aureus (MRSA), Vancomycin resistant Enterococcus faecalis (VRE) as well as fungi such as Candida albicans and Aspergillus niger.

Recalls

DateFirmReason
2026-06-08ConvaTec, IncSurgical dressing manufactured out of specification (greater thickness).
2026-04-27Oculus Technologies of Mexico, S.A. de C.V.The recall is being conducted due to corrosion of the internal metallic spring within the sprayer component. This condition is caused by material incompatibility between the produc
2026-01-16Integra LifeSciences Corp. (NeuroSciences)Potential packaging failures, which could lead to a breach in the sterile barrier.
2026-01-16Integra LifeSciences Corp. (NeuroSciences)Potential packaging failures, which could lead to a breach in the sterile barrier.
2026-01-16Integra LifeSciences Corp. (NeuroSciences)Potential packaging failures, which could lead to a breach in the sterile barrier.
2026-01-05Medline Industries, LPMedline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for
2026-01-05Medline Industries, LPMedline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for
2025-08-05Integra LifeSciences Corp. (NeuroSciences)Packaging failures were identified which could lead to a breach in the sterile barrier.
2025-08-05Integra LifeSciences Corp. (NeuroSciences)Packaging failures were identified which could lead to a breach in the sterile barrier.
2025-08-05Integra LifeSciences Corp. (NeuroSciences)Packaging failures were identified which could lead to a breach in the sterile barrier.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.